Search research articles
Contact Us
Filters
Showing results (431-440 of 529) with videos related to
Page
of 53
Sort By:
NPJ Precision Oncology
|
June 19, 2024
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer
Dylan M Glubb, Elisa Cerri, Alexandra Giese, et al.
Oncotarget
|
April 19, 2017
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
Koji Ando, Ankur K Shah, Vibhu Sachdev, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2021
The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin <i>β</i>-Like 1-<i>β</i>-Catenin Protein Complex
Raffaella Soldi, Tithi Ghosh Halder, Samuel Sampson, et al.
Biophysics Reviews
|
March 20, 2024
Intrinsically disordered proteins: Ensembles at the limits of Anfinsen's dogma
Prakash Kulkarni, Vitor B P Leite, Susmita Roy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 27, 2011
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer
Michael D Hasselle, Daniel J Haraf, Kyle E Rusthoven, et al.
Cancer Biology & Therapy
|
October 13, 2018
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma
Jiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
Amikar Sehdev, Theodore Karrison, Yuanyuan Zha, et al.
NPJ Precision Oncology
|
October 29, 2025
Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment
Kevin Lu, John Paul Shen, Fernando J Lopez-Diaz, et al.
Frontiers in Oncology
|
May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
Bridget E Crossman, Regan L Harmon, Mari Iida, et al.
Page
of 53
Search research articles
Search
Showing results (431-440 of 529) with videos related to
Sort By:
Page
of 53
NPJ Precision Oncology
|
June 19, 2024
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer
Dylan M Glubb, Elisa Cerri, Alexandra Giese, et al.
Oncotarget
|
April 19, 2017
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
Koji Ando, Ankur K Shah, Vibhu Sachdev, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2021
The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin <i>β</i>-Like 1-<i>β</i>-Catenin Protein Complex
Raffaella Soldi, Tithi Ghosh Halder, Samuel Sampson, et al.
Biophysics Reviews
|
March 20, 2024
Intrinsically disordered proteins: Ensembles at the limits of Anfinsen's dogma
Prakash Kulkarni, Vitor B P Leite, Susmita Roy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 27, 2011
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer
Michael D Hasselle, Daniel J Haraf, Kyle E Rusthoven, et al.
Cancer Biology & Therapy
|
October 13, 2018
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma
Jiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
Amikar Sehdev, Theodore Karrison, Yuanyuan Zha, et al.
NPJ Precision Oncology
|
October 29, 2025
Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment
Kevin Lu, John Paul Shen, Fernando J Lopez-Diaz, et al.
Frontiers in Oncology
|
May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
Bridget E Crossman, Regan L Harmon, Mari Iida, et al.
Page
of 53